Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Shengquan and Novozymes in partnership to commercialize cellulosic ethanol

Published: Friday, May 11, 2012
Last Updated: Friday, May 11, 2012
Bookmark and Share
The Chinese Shengquan Group will start commercial production of cellulosic ethanol for solvents and biochemicals in June 2012 utilizing enabling technology from Novozymes

Shengquan Group, a Shandong-based company specializing in furan resin and polymers, and Novozymes, a world leader in bioinnovation, has announced a partnership enabling Shengquan to start commercial-scale production of cellulosic ethanol for solvents in June 2012 using Novozymes’ technology.

“Shengquan is a global first mover in this industry, which is on the verge of materializing right now,” says Poul Ruben Andersen, Vice President for Bioenergy at Novozymes. “Shengquan has profound experience in chemical production and is a leading company in commercializing cellulosic ethanol. Novozymes is proud to join Shengquan in nurturing a green and circular bioeconomy which lessens the dependence on fossil fuel resources.”

Shengquan is a leading producer of furfural using xylose in corncobs, a monomer for resin production in the foundry industry. Using Novozymes enzymes, Shengquan will now convert corncob residues from furfural production into fermentable sugars and then into ethanol for solvents and other purposes. Shengquan’s cost model shows that its current production cost of cellulosic ethanol is cost-competitive with conventional ethanol as the feedstock is a by-product of their current production.

Novozymes is a leading enzymatic solution provider in bioenergy. It partners with leading producers of cellulosic ethanol all over the world to commercialize this new technology.
 
Biofuels boost the economy and create jobs

A recent study by Bloomberg New Energy Finance estimates that the advanced biofuel industry has the potential to create millions of jobs, economic growth and energy security worldwide.

Looking at China alone, the study shows that using less than 20% of the available agricultural residues China could produce more than 89 billion liters (23 million gallons) of biofuel, replacing 37% of its gasoline consumption by 2030. This would create 2.9 million jobs and reduce CO2 emissions from gasoline-based transportation by 29%. The figures would be even higher if biomass from forestry residues, household waste and energy crops was included.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Novozymes and Syngenta to partner in delivering JumpStart® — For enhanced phosphate fertility within bioagriculture
The agreement provides an exclusive expansion into new markets for JumpStart, which is a biological that enhances phosphate fertility in agriculture, offering growers an integrated and sustainable seed care solution
Friday, May 11, 2012
Novozymes Announces Master File for Recombinant Albumin
The dossier, containing information on the manufacture and safety of albucult, can help support the medical devices and drug formulation applications.
Friday, September 03, 2010
Scientific News
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Applying Deep Learning to Drug Discovery
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!